Keywords: GLP-1 receptor agonists, neuroprotection, neuroinflammation, Alzheimers disease, Parkinsons disease Introduction Neurological disorders are a leading cause of death and disability worldwide and place a huge burden on patients, families, and healthcare systems
Yan, J., Ran, M., Shen, X
Lawyers are pursuing Ozempic, Wegovy and Mounjaro lawsuits over serious side effects, including stomach paralysis, other gastrointestinal injuries and NAION, a rare optic nerve injury linked to sudden and potentially permanent vision loss
The honest way to hold this fact is in two hands at once: the causal link was not proven, and the episode is nonetheless a real part of why the DAC form never advanced and why the compound class is treated with caution
The relationship between these peptides illustrates the drug development process: MT-2 was the discovery compound, PT-141 was the optimized derivative, and only PT-141 completed the journey to approval